Chronic Obstructive Pulmonary Disease
Conditions
Interventions
Intervention group:Intelligent Medication Management Assistant Intervention for COPD
Control group:Usual care
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Be at least 18 years old. 2.Clinically diagnosed with chronic obstructive pulmonary disease by a physician; 3.Inhaled therapy status meets any of the following conditions: previously received inhaled therapy and continue to use it after enrollment; ?initiating inhaled therapy for the first time at enrollment; 4.Patients who use an appropriate type of inhaler after measurement of peak inspiratory flow rate; 5.Willing to participate in this clinical study and sign written informed consent voluntarily.
Exclusion criteria
Exclusion criteria: 1.Inability to obtain informed consent from the patient or their family members. 2. 4. 5. Patients with limited mobility, motor function restrictions, or other reasons that are expected to prevent completion of long-term follow-up. 6. Currently participating in other pharmaceutical intervention studies. 7. Other situations where the pharmacist determines that the study subject cannot comply with the trial protocol. 2.Pregnant patients. 3.Patients with terminal illness, malignant tumors, tuberculosis, cardiopulmonary failure, or those who are unable to cooperate with pulmonary function testing due to their disease status. 4.As determined by a doctor, there are cognitive and mental functional disorders, with severe visual, auditory and communication impairments There are obstacles, as well as other circumstances that affect the technical use of inhalers. 5.Due to mobility issues, motor function limitations or other reasons, it is expected that long-term follow-up cannot be completed. 6.The situation of being involved in other pharmaceutical intervention studies. 7.Other circumstances where the research subject is determined by the pharmacist to be unable to comply with the trial plan.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication Adherence Rate;Score of the Adherence to Refills and Medications Scale (ARMS-12);Quality of life score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient usage experience survey score;Chronic obstructive pulmonary disease assessment test; | — |
Countries
China
Contacts
Public ContactLihong Liu
China-Japan Friendship Hospital
Outcome results
None listed